We are live on
!
Find out more
AIM
Artemis Investment Management Portfolio holdings
AUM
$11.2B
1-Year Est. Return
80.72%
This Fund
S&P 500
This Quarter
Est. Return
+9.4%
1 Year Est. Return
+80.72%
3 Year Est. Return
+256.46%
5 Year Est. Return
+371.57%
10 Year Est. Return
+1,554.26%
AUM
$11.6B
AUM Growth
+$1.05B
(+10%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
2%
Top 10 Holdings %
Top 10 Hldgs %
22.26%
Holding
324
New
78
Increased
114
Reduced
82
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$123M |
| 2 |
Amazon
AMZN
|
+$78.7M |
| 3 |
Bio-Techne
TECH
|
+$67.7M |
| 4 |
SBNY
Signature Bank
SBNY
|
+$66.6M |
| 5 |
Apple
AAPL
|
+$63.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$94.2M |
| 2 |
Ally Financial
ALLY
|
+$92.7M |
| 3 |
Uber
UBER
|
+$78.6M |
| 4 |
Freeport-McMoran
FCX
|
+$73.3M |
| 5 |
Fidelity National Information Services
FIS
|
+$69.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.3% |
| 2 | Technology | 19.7% |
| 3 | Industrials | 14.19% |
| 4 | Consumer Discretionary | 12.72% |
| 5 | Healthcare | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Beyond Meat
BYND
$268M
| $1.63M | 0.01% |
+10,367
| New | +$1.38M |
|
252
Clear Secure
YOU
$5.27B
| $1.61M | 0.01% |
+40,000
| New | +$1.6M |
|
253
Insulet
PODD
$9.91B
| $1.61M | 0.01% |
+5,857
| New | +$1.59M |
|
254
Iovance Biotherapeutics
IOVA
$2.9B
| $1.55M | 0.01% |
+59,462
| New | +$1.55M |
|
|
BAND
255
Bandwidth Inc
BAND
$1.7B
| $1.54M | 0.01% |
+11,187
| New | +$1.4M |
|
|
ARNA
256
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.52M | 0.01% |
+22,231
| New | +$1.45M |
|
|
DOCU
257
DocuSign
DOCU
$11.4B
| $1.49M | 0.01% |
+5,340
| New | +$1.19M |
|
258
United Therapeutics
UTHR
$22.7B
| $1.45M | 0.01% |
+8,090
| New | +$1.54M |
|
|
TRHC
259
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.44M | 0.01% |
+28,762
| New | +$1.29M |
|
260
TSMC
TSM
$2.17T
| $1.41M | 0.01% |
11,696
-507
| -4% | -$59.4K |
|
261
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.39M | 0.01% |
5,000
| – | – |
|
|
MRTX
262
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.38M | 0.01% |
+8,525
| New | +$1.37M |
|
263
Teradyne
TER
$57.1B
| $1.38M | 0.01% |
+10,252
| New | +$1.31M |
|
|
XLRN
264
DELISTED
Acceleron Pharma
XLRN
| $1.36M | 0.01% |
+10,859
| New | +$1.37M |
|
265
Sarepta Therapeutics
SRPT
$1.81B
| $1.31M | 0.01% |
+16,852
| New | +$1.28M |
|
266
Xometry
XMTR
$5.19B
| $1.3M | 0.01% |
+15,000
| New | +$1.31M |
|
|
ONT
267
Onterris Inc
ONT
$546M
| $1.27M | 0.01% |
+23,648
| New | +$1.24M |
|
268
STAAR Surgical
STAA
$1.25B
| $1.26M | 0.01% |
+8,273
| New | +$1.09M |
|
269
Penumbra
PEN
$12.8B
| $1.25M | 0.01% |
+4,555
| New | +$1.24M |
|
270
Universal Display
OLED
$4.16B
| $1.18M | 0.01% |
+5,322
| New | +$1.17M |
|
271
Tetra Tech
TTEK
$8.97B
| $1.11M | 0.01% |
+45,325
| New | +$1.14M |
|
272
Tesla
TSLA
$1.31T
| $1.09M | 0.01% |
+4,809
| New | +$1.04M |
|
273
Unity
U
$19B
| $1.08M | 0.01% |
+9,858
| New | +$969K |
|
274
Veracyte
VCYT
$3.72B
| $970K | 0.01% |
+24,237
| New | +$1.04M |
|
|
EBIX
275
CALL
DELISTED
Ebix Inc
EBIX
| $887K | 0.01% |
+25,500
| New | +$790K |
|
Similar funds
DCP
BHCM
GKIM
VLKIM
ERSOT
DWM
HTC
Artemis Investment Management's Q2 2021 Portfolio in Review
As of Q2 2021, Artemis Investment Management held 324 positions worth $11.6B, up 10% from $10.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Artemis Investment Management's Q2 2021 filing shows 78 new, 114 increased, 82 reduced and 45 closed positions. Its largest new stake was Splunk Inc: 968,725 shares worth $140M. The largest sale was Broadcom, an estimated $94.2M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.
- Artemis Investment Management's largest Q2 2021 buy was Splunk Inc: 968,725 shares worth $140M.
- Artemis Investment Management added most to Amazon in Q2 2021, an estimated $78.7M increase.
- Artemis Investment Management's biggest Q2 2021 reduction was Broadcom, cutting an estimated $94.2M.
- Artemis Investment Management fully exited Fidelity National Information Services in Q2 2021, selling an estimated $69.6M.
- Artemis Investment Management's ten largest holdings make up 22% of its $11.6B portfolio in Q2 2021.
- Artemis Investment Management opened 78 new positions and closed 45 in Q2 2021.
- Artemis Investment Management's portfolio value rose 10% quarter-over-quarter to $11.6B.
Based on Artemis Investment Management's 13F filing for Q2 2021, filed 4 Aug 2021.